Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,400 people across 40 countries.
Medpace Expands Ophthalmology Medical Leadership Team October 23, 2024 8:19am
Medpace is pleased to announce the addition of a new ophthalmology expert, Dr. Karen Klugo, to the medical leadership team.
The post Medpace Expands Ophthalmology Medical Leadership Team appeared first on Medpace Corporate.
View this post
[Upcoming Webinar] Accelerating Psychiatry Clinical Trials Through a Patient-Centric Approach: Real Patients, Real Outcomes October 1, 2024 8:23am
In this webinar, Medpace neuroscience clinical trial experts will explore strategies for successfully conducting psychiatry clinical trials.
The post [Upcoming Webinar] Accelerating Psychiatry Clinical Trials Through a Patient-Centric Approach: Real Patients, Real Outcomes appeared first on Medpace Corporate.
View this post
Oncology Breakthroughs – ESMO Congress 2024 September 25, 2024 3:43pm
Upon their return from ESMO Congress 2024 and in recognition of World Cancer Research Day, Medpace oncology experts identified three...
The post Oncology Breakthroughs – ESMO Congress 2024 appeared first on Medpace Corporate.
View this post
[Upcoming Webinar] Innovative Approaches in MASH Clinical Research September 20, 2024 2:56pm
The evolving landscape of metabolic dysfunction-associated steatohepatitis (MASH) research demands precise and reliable methodologies to ensure accurate data collection and...
The post [Upcoming Webinar] Innovative Approaches in MASH Clinical Research appeared first on Medpace Corporate.
View this post
Medpace Expands Rare Disease & Metabolic Medical Leadership Team September 18, 2024 8:16am
Medpace is pleased to announce the addition of a new rare disease and metabolic expert, Dr. Loren Peña, to the medical leadership team.
The post Medpace Expands Rare Disease & Metabolic Medical Leadership Team appeared first on Medpace Corporate.
View this post
Expert Insights: Late-Breaking Science Emerging from ACC.24 September 16, 2024 10:21am
At Medpace, we remain committed to shaping the future of cardiovascular care through our ongoing work with sponsors and research...
The post Expert Insights: Late-Breaking Science Emerging from ACC.24 appeared first on Medpace Corporate.
View this post